You are here
AusPAR: Elasomeran
Related information
Australian Public Assessment Report
4 August 2022
| AusPAR | |
|---|---|
| Active Ingredient | Elasomeran
|
| Product Name | Spikevax
|
| Sponsor | Moderna Australia Pty Ltd
|
| Submission Number | PM-2022-01792-1-2 and PM-2022-01760-1-2
|
| Submission Type | Extension of indication and major variation (new strength)
|
| Decision | Approved for provisional registration
|
| AusPAR Date | 27 July 2022
|
| Publication Date | 4 August 2022 |